Agathos Biologics announced today that it has signed a lease with Comstock Companies to acquire additional laboratory and office space, bringing its total to 10,000 square feet of usable space. “We are excited to expand our footprint in Fargo, North Dakota, which continues to see growth in its biotechnology industry,” said James Brown, CEO of Agathos. “The space is purpose-built for laboratory research, which will allow us to immediately increase our capacity to support our pipeline of projects.”
“We are pleased to see the growth of Agathos, adding to the space leased by life science tenants, including Sanford Health and Immunoprecise, in our research center, the former PRACS building,” said Scott Kjos, Managing Partner of Comstock Companies. “We are eager to support the growing biotechnology industry in Fargo and adding facilities and infrastructure that will enable these companies to have a positive impact on human health.”
Founded by James Brown, John Ballantyne, and Michael Chambers, Agathos Biologics is pursuing opportunities in gene therapy, nucleic acid and protein delivery, and biomanufacturing. Agathos’ mission as The Good Science Company is creation of transformative technologies benefiting patients, physicians, and researchers that are developed ethically, avoiding biological materials from sources including human embryonic stem cells and aborted fetal tissue and procuring materials with proper consent.
“The founders of Agathos Biologics believe that the explosive growth of biotechnology enables us to provide ethical alternatives to existing biomaterials that will allow us all to live healthier lives without compromising our deeply held beliefs. We look forward to leading this new approach and working within the industry to realize this vision,” added Brown.